Functionalization of β-cyclodextrin with a urea-based PSMA ligand and preliminary studies on targeting prostate cancer cells

Keyphrases

• Prostate Cancer Cells 100%
• β-cyclodextrin (β-CD) 100%
• Urea-based 100%
• Prostate-specific Membrane Antigen 100%
• Doxorubicin 33%
• Tumoral Cells 33%
• Prostate 33%
• Cancer Cells 16%
• Overexpressing 16%
• Drug Administration 16%
• Drug Target 16%
• Urea 16%
• Cytotoxicity 16%
• Dipeptide 16%
• Malignant Cells 16%
• Antineoplastic Agents 16%
• Targeted Drug Delivery 16%
• Membrane Protein 16%
• Drug Delivery System 16%
• LNCaP Cells 16%
• LNCaP 16%
• Side Effects of Therapy 16%
• Selective Ligands 16%
• Promising Drug 16%
• Targeting Mechanism 16%
• Selective Drugs 16%
• Multivalent Drugs 16%
• Drug Delivery Approaches 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Prostate Specific Membrane Antigen 100%
• Cyclodextrin 100%
• Urea 100%
• Doxorubicin 33%
• Beta Cyclodextrin 33%
• Malignant Neoplasm 16%
• Drug Administration 16%
• Drug Delivery System 16%
• Dipeptide 16%
• Anticarcinogen 16%
• Blood Group A Antigen 16%
• Membrane Protein 16%
• Cytotoxicity 16%
• Side Effect 16%